CompletedNot Applicable

Study of a Candidate Gene Involved in Goldenhar Syndrome.

248 participantsStarted 2012-09-29

Plain-language summary

The aim of this study is to identify of the first gene involved in the Goldenhar syndrome in a cohort of 120 affected patients.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Spectrum of oculoauriculovertebral dysplasia minimal features include unilateral microtia and hemifacial microsomia Exclusion Criteria: * Absence of minimal spectrum of oculoauriculovertebral dysplasia features, molecular anomaly identified, other diagnosis

What they're measuring

presence of sequence variation

Timeframe: At the screening

Trial details

NCT IDNCT04056858

SponsorUniversity Hospital, Bordeaux

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2014-01-08

View on ClinicalTrials.gov More Goldenhar Syndrome trials